Navigation Links
Roche Receives FDA Clearance for U.S. Launch of cobas 8000 Modular Analyzer Series for High-Volume Laboratory Testing
Date:9/13/2010

management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80,000 employees worldwide and invested almost 10 billion Swiss francs in R&D. The Group posted sales of 49.1 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com or www.roche-diagnostics.us.

All trademarks used or mentioned in this release are protected by law.

For further information, please contact: Betsy Cox Director, Corporate Communications

Roche Diagnostics Corporation

Indianapolis, IN(317) 521-3911betsy.cox@roche.com
'/>"/>

SOURCE Roche Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
3. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
4. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
5. Roche Announces Positive Results in Solid Tumors Using Human Monoclonal Antibody Against IGF-1R (R1507)
6. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
7. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
8. Two Pivotal Phase III Studies for Roches ACTEMRA(TM) (tocilizumab) Demonstrate Significant Improvement in Rheumatoid Arthritis Symptoms
9. Roche Submits Application for FDA Approval of ACTEMRA(R) for the Treatment of Rheumatoid Arthritis
10. Roche responds to announcement of IDEAL hepatitis C trial results
11. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... , Sept. 3,  2015 ... human-made bio-artificial devices, which are implanted or ... natural organs. These include artificial heart, kidney, ... as polymers (polyurethane, polysulfone, and porous polypropylene), ... develop artificial organs. These organs are incorporated ...
(Date:9/3/2015)... Sept. 3, 2015 About dry eye syndrome ... due to deficient tear production or quick tear evaporation ... two types: aqueous tear deficient dry eye and evaporative ... glands do not produce enough tears, whereas meibomian gland ... lipids to slow tear evaporation and maintain tear stability. ...
(Date:9/3/2015)... 2015  Ascendis Pharma A/S (Nasdaq: ... that applies its innovative TransCon technology to ... plans to present at several upcoming investor ... in BostonDate: , Thursday, September 10, 2015 Time: ... Merrill Lynch Global Healthcare Conference in LondonDate: ...
Breaking Medicine Technology:Global Artificial Organ Market 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2
... , Ruling Opens Door to Physician Assisted ... Montana Supreme Court ruled that state law does not contain ... drugs to patients. This decision endangers the lives of the ... people,s lives, the law needs to draw a clear distinction ...
... For the twelfth consecutive year, Rev. Nicholas Hood, III, ... save lives during New Year,s Eve celebrations. Rev. Hood, ... Plan (HAP) and the Wayne County Sheriff,s Office, is asking ... without gunfire. The hope is that there will be ...
Cached Medicine Technology:Montana Supreme Court Decision Endangers Most Vulnerable Citizens 2Rev. Nick Hood, III Asks Southeast Michiganders Not to Use Guns During New Year's Eve Celebrations 2
(Date:9/4/2015)... ... September 04, 2015 , ... Inmar announced today that ... of its Product, Quality and Manufacturers, Dietary Supplements and Supply Chain Committees. , ... the consumer goods industry, it can be difficult for companies to navigate, stay ...
(Date:9/4/2015)... ... 04, 2015 , ... “Getting away from the daily stressors and distractions of ... strengthen their ‘couple-ness,’” says Jean Claude Wietzel, general manager at Four Seasons Resort ... island’s only Forbes Five Star resort and Travel + Leisure’s No. 1 Hotel in ...
(Date:9/4/2015)... ... September 04, 2015 , ... The conference ... in Hollywood, Florida October 9-10, 2015 at the Diplomat Resort & Spa has ... are doctors and researchers at the top of their field and will be ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... comparison to settlements under the Stark physician self-referral law. “Stark Law DOs ... webinar from Atlantic Information Services, Inc. (AIS), will detail which deals are attracting ...
(Date:9/3/2015)... WI (PRWEB) , ... September 04, 2015 , ... ... month of September. , "There are so many children and adults who don't ... Wisconsin," says Dr. Sara Mahalko-Leonhardt. "We love holding our annual Coat Drive to help ...
Breaking Medicine News(10 mins):Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:AlignLife is Helping to Keep the Community Warm This Winter 2
... study that was lead by Joslin Diabetes Centre throws ... and function. These findings// they hope will help in ... Joslin Diabetes Centre in Boston, have conducted a study ... insulin-producing beta cell do not affect in the developmental ...
... (NACO) will increase the number of centres that assess the ... are planning to add 400 sites (to the existing 750 ... of people affected by HIV/AIDS,' said K. Sujatha Rao, additional ... a three-day national seminar in the capital Sunday. ...
... influence of ocean currents in climate change and the story ... that seem to be holding the clue. ,An ... tiny fish teeth has offered a clue to the University ... between Atlantic and Pacific might have opened up. This ...
... explain why men and women experience pain differently and ... pain-relief drugs, reveals a new study conducted by researchers ... Behavioral Neuroscience (CBN). ,Although the study has ... similar differences occur in humans as well. The results ...
... As a plan to reduce illegal trading and as a ... in Vancouver. Vancouver’s mayor is considering providing free drugs to ... 2010 Winter Olympics. ,According to Sam Sullivan a ... innovative harm-reduction program is the spearhead. ,The reason and ...
... profession was the second person in the world to undergo a ... is stable but the success of the operation could be revealed ... in china. The doctors reported to the press that Mr. Li ... thirty years old and was attacked by a black bear. In ...
Cached Medicine News:Health News:A New study Throws Light On The Growth & Functions Of Insulin Producing Beta Cells 2Health News:A New study Throws Light On The Growth & Functions Of Insulin Producing Beta Cells 3Health News:Gender Difference In Pain Experience Explained By Brain Diversity 2
The Opteon stem meets the challenge of providing a high-quality, cost-effective hip implant for the moderate demand patient....
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The uncemented hip joint prosthesis system....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Medicine Products: